Q1 2018 Holdings
Filed 2018-05-15 | 55 holdings | $222.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Ascendis Pharma A/S(ASND) | Common Stock | 04351P101 | $162.2M | 2,479,514 | 72.9% |
| Coherus BioSciences, Inc.(CHRS) | Common Stock | 19249H103 | $32.0M | 2,893,221 | 14.4% |
| Aclaris Therapeutics, Inc.(ACRS) | Common Stock | 00461U105 | $27.0M | 1,539,480 | 12.1% |
| Ardelyx, Inc.(ARDX) | Common Stock | 039697107 | $501.0K | 99,166 | 0.2% |
| Catalyst Pharmaceuticals, Inc.(CPRX) | Common Stock | 14888U101 | $354.0K | 148,055 | 0.2% |
| NuCana plc | American Depositary Shares | 67022C106 | $88.3K | 4,666,666 | 0.0% |
| ObsEva SA | Common Stock | H5861P103 | $64.1K | 4,749,623 | 0.0% |
| Audentes Therapeutics(BOLDEUR) | Common Stock | 05070R104 | $41.5K | 1,380,303 | 0.0% |
| Merus N.V. | Common Stock | N5749R100 | $36.3K | 1,961,039 | 0.0% |
| Spark Therapeutics, Inc. | Common Stock | 84652J103 | $32.0K | 481,270 | 0.0% |
| Natera, Inc.(NTRA) | Common Stock | 632307104 | $28.7K | 3,100,560 | 0.0% |
| Apellis Pharmaceuticals, Inc(APLS) | Common Stock | 03753U106 | $20.2K | 911,752 | 0.0% |
| Amarin Corp PLC | Common Stock | 023111206 | $10.0K | 3,321,588 | 0.0% |
| Histogenics Corporation | Common Stock | 43358V109 | $5.7K | 2,077,040 | 0.0% |
| Synlogic, Inc. | Common Stock | 87166L100 | $5.4K | 574,972 | 0.0% |
| aTyr Pharma Inc(LIFEUSD) | Common Stock | 002120103 | $4.9K | 1,866,126 | 0.0% |
| Edge Therapeutics, Inc. | Common Stock | 279870109 | $3.4K | 2,852,711 | 0.0% |
| Chiasma, Inc.(CHMA) | Common Stock | 16706W102 | $2.4K | 1,630,221 | 0.0% |
| Allergan plc | Common Stock | G0177J108 | $1.6K | 9,379 | 0.0% |
| Auris Medical Holding AG | Common Shares | H0381L104 | $1.3K | 781,818 | 0.0% |
| Alexion Pharmaceuticals, Inc.(ALXN) | Common Stock | 015351109 | $1.0K | 9,126 | 0.0% |
| Bristol-Myers Squibb Company(BMY) | Common Stock | 110122108 | $951 | 15,033 | 0.0% |
| Heron Therapeutics, Inc.(HRTX) | Common Stock | 427746102 | $832 | 30,133 | 0.0% |
| Kadmon Holdings, Inc.(KDMN) | Common Stock | 48283N106 | $794 | 186,774 | 0.0% |
| AstraZeneca PLC(AZN) | ADRS | 046353108 | $763 | 21,832 | 0.0% |
| PTC Therapeutics, Inc.(PTCT) | Common Stock | 69366J200 | $696 | 25,729 | 0.0% |
| Aimmune Therapeutics, Inc.(AIMT) | Common Stock | 00900T107 | $646 | 20,308 | 0.0% |
| Radius Health Inc. | Common Stock | 750469207 | $605 | 16,847 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | Common Stock | 75615P103 | $603 | 29,383 | 0.0% |
| Iovance Biotherapeutics, Inc.(IOVA) | Common Stock | 462260100 | $523 | 30,958 | 0.0% |
| Regeneron Pharmaceuticals, Inc.(REGN) | Common Stock | 75886F107 | $449 | 1,304 | 0.0% |
| Otonomy, Inc. | Common Stock | 68906L105 | $414 | 98,624 | 0.0% |
| GW Pharmaceuticals PLC | Common Stock | 36197T103 | $410 | 3,637 | 0.0% |
| Adamas Pharmaceuticals, Inc.(ADMSEUR) | Common Stock | 00548A106 | $387 | 16,206 | 0.0% |
| Dermira, Inc.(DERMEUR) | Common Stock | 24983L104 | $386 | 48,320 | 0.0% |
| Clearside Biomedical, Inc.(CLSDUSD) | Common Stock | 185063104 | $380 | 35,379 | 0.0% |
| Ionis Pharmaceuticals, Inc.(IONS) | Common Stock | 462222100 | $374 | 8,476 | 0.0% |
| Foamix Pharmaceuticals Ltd. | Common Stock | M46135105 | $369 | 72,017 | 0.0% |
| Rigel Pharmaceuticals, Inc.(RIGLUSD) | Common Stock | 766559603 | $365 | 102,974 | 0.0% |
| MediciNova, Inc.(MNOV) | Common Stock | 58468P206 | $336 | 32,875 | 0.0% |
| Kala Pharmaceuticals, Inc. | Common Stock | 483119103 | $323 | 20,409 | 0.0% |
| Mirati Therapeutics, Inc.(MRTXEUR) | Common Stock | 60468T105 | $267 | 8,688 | 0.0% |
| Rigel Pharmaceuticals, Inc(RIGLUSD)Put | Common Stock | 766559603 | $252 | 71,300 | 0.0% |
| Spectrum Pharmaceuticals Inc.Call | Common Stock | 84763A108 | $241 | 15,000 | 0.0% |
| OncoMed Pharmaceuticals, Inc. | Common Stock | 68234X102 | $213 | 67,033 | 0.0% |
| Exelixis Inc(EXEL)Call | Common Stock | 30161Q104 | $206 | 9,300 | 0.0% |
| Affimed N.V. | Common Stock | N01045108 | $205 | 110,834 | 0.0% |
| Sierra Oncology, Inc. | Common Stock | 82640U107 | $203 | 98,126 | 0.0% |
| Stemline Therapeutics Inc | Common Stock | 85858C107 | $193 | 12,640 | 0.0% |
| Syndax Pharmaceuticals, Inc.(SNDX) | Common Stock | 87164F105 | $173 | 12,124 | 0.0% |